Found: 76
Select item for more details and to access through your institution.
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Diffusion-weighted MRI for uveal melanoma liver metastasis detection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Switch to Fulvestrant Upon Early Signs of Rising ESRl Mutations Improves Outcomes in HR-Positive Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2022, p. 16
- By:
- Publication type:
- Article
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 1, p. 180, doi. 10.1002/eji.202049058
- By:
- Publication type:
- Article
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
- Published in:
- Cancer & Metastasis Reviews, 2013, v. 32, n. 1/2, p. 179, doi. 10.1007/s10555-012-9398-0
- By:
- Publication type:
- Article
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 3, p. 579, doi. 10.1007/s10549-023-07201-w
- By:
- Publication type:
- Article
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 1, p. 43, doi. 10.1007/s10549-023-06998-w
- By:
- Publication type:
- Article
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 200, n. 3, p. 43, doi. 10.1007/s10549-023-06998-w
- By:
- Publication type:
- Article
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00862-6
- By:
- Publication type:
- Article
Biologie du processus métastatique.
- Published in:
- Médecine Sciences, 2012, v. 28, n. 1, p. 89, doi. 10.1051/medsci/2012281022
- By:
- Publication type:
- Article
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating tumor cells: clinical validity and utility.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 3, p. 421, doi. 10.1007/s10147-017-1105-2
- By:
- Publication type:
- Article
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144359
- By:
- Publication type:
- Article
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067148
- By:
- Publication type:
- Article
Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047390
- By:
- Publication type:
- Article
Insights from ASCO 2023.
- Published in:
- 2023
- By:
- Publication type:
- Proceeding
Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz050
- By:
- Publication type:
- Article
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz049
- By:
- Publication type:
- Article
Circulating Tumor Cells in Early Breast Cancer.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 2, p. N.PAG, doi. 10.1093/jncics/pkz026
- By:
- Publication type:
- Article
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00319-4
- By:
- Publication type:
- Article
Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0068-4
- By:
- Publication type:
- Article
PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 15, p. 4882, doi. 10.3390/jcm12154882
- By:
- Publication type:
- Article
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092114
- By:
- Publication type:
- Article
Deciphering HER2-HER3 Dimerization at the Single CTC Level: A Microfluidic Approach.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1890, doi. 10.3390/cancers14081890
- By:
- Publication type:
- Article
Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 140, doi. 10.3390/cancers13010140
- By:
- Publication type:
- Article
Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 396, doi. 10.3390/cancers11030396
- By:
- Publication type:
- Article
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical utility of circulating tumor cells: an update.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 6, p. 1647, doi. 10.1002/1878-0261.12869
- By:
- Publication type:
- Article
International study on inter-reader variability for circulating tumor cells in breast cancer.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 2, p. 1, doi. 10.1186/bcr3647
- By:
- Publication type:
- Article
International study on inter-reader variability for circulating tumor cells in breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2015, v. 34, n. 1, p. 1, doi. 10.1186/S13046-015-0128-7
- By:
- Publication type:
- Article
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 8, p. 1093, doi. 10.1093/clinchem/hvaa121
- By:
- Publication type:
- Article
High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 4, p. 606, doi. 10.1093/clinchem/hvaa013
- By:
- Publication type:
- Article
Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.
- Published in:
- Clinical Chemistry, 2018, v. 64, n. 2, p. 317, doi. 10.1373/clinchem.2017.272518
- By:
- Publication type:
- Article
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 3, p. 691, doi. 10.1373/clinchem.2016.262337
- By:
- Publication type:
- Article
Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1164, doi. 10.2967/jnumed.123.265434
- By:
- Publication type:
- Article
HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 8, p. 1667, doi. 10.1002/ijc.30863
- By:
- Publication type:
- Article
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 9, p. 2158, doi. 10.1002/ijc.29265
- By:
- Publication type:
- Article
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 5, p. 1207, doi. 10.1002/ijc.28436
- By:
- Publication type:
- Article
Going with the Flow: From Circulating Tumor Cells to DNA.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 207, p. 1, doi. 10.1126/scitranslmed.3006305
- By:
- Publication type:
- Article
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A DNA methylation-based liquid biopsy for triple-negative breast cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00198-9
- By:
- Publication type:
- Article
18 F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 8, p. 1353, doi. 10.3390/diagnostics11081353
- By:
- Publication type:
- Article
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 516, doi. 10.3390/cells8060516
- By:
- Publication type:
- Article